Technology
Health
Biotechnology

ADMA Biologics

$3.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-2.68%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ADMA Biologics and other stocks, options, ETFs, and crypto commission-free!

About ADMA

ADMA Biologics, Inc. operates as a biopharmaceutical company. It develops, manufactures, and intends to commercialize in human plasma and plasma-derived therapeutics. Read More The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.

Employees
318
Headquarters
Ramsey, New Jersey
Founded
2006
Market Cap
172.90M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
584.61K
High Today
$3.76
Low Today
$3.62
Open Price
$3.76
Volume
547.85K
52 Week High
$6.96
52 Week Low
$2.08

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Therapy
Manufacturing
Pharmaceutical
2013 IPO

ADMA Earnings

-$0.39
-$0.34
-$0.29
-$0.24
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.